EVOQ Remedies Ltd.
Snapshot View

14.20 ▼0%

01 February 2023, 04:01:00 PM

Overview View Details >>

Sector Trading Compare with Sector peers
Industry Trading Compare with Industry peers
Website http://www.evoqremedies.com
Market Cap 19.31 Cr.
Enterprise Value(EV) 24.38 Cr. 2022-03
Financial Indicators
Earnings per share (EPS) 0.80 Trailing Twelve Months Ending 2022-03
Price-Earning Ratio (PE) 17.70 Trailing Twelve Months Ending 2022-03
Industry PE 40.91 Trailing Twelve Months Ending 2022-03
Book Value / Share 17.03 Trailing Twelve Months Ending 2022-03
Price to Book Value 0.83 Calculated using Price: 14.20
Dividend Yield 0.00 Period Ending 2022-03
No. of Shares Subscribed 1.36 Cr. 13,600,000 Shares
FaceValue 10
Company Profile
No Company Profile found.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
1 Week
-8.39%
1 Month
3 Month
-7.49%
6 Month
+1.50%
1 Year
2 Year
5 Year
10 Year
4 years 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) 49.78 1.34 186.89 9.13
Return on Capital Employed (%) 68.94 2.69 246.90 9.12
Return on Assets (%) 0.52 0.01 10.45 5.27

Balance Sheet View Details >>

Particulars 4 years 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Shh. Funds 0 0 1 23
Non Curr. Liab. 0
Curr. Liab. 2 6 7 10
Minority Int.
Equity & Liab. 2 6 8 33
Non Curr. Assets
Curr. Assets 2 6 8 33
Misc. Exp. not W/O
Total Assets 2 6 8 33

Profit Loss View Details >>

Particulars 4 years 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Net Sales 3 9 10 17
Other Income
Total Income 3 9 10 17
Total Expenditure -3 -9 -9 -15
PBIDT 0 1 1
Interest
Depreciation
Taxation 0 0
Exceptional Items
PAT 0 1 1
Adjusted EPS 10 1

Cash Flow View Details >>

Particulars 4 years 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 0 0 0 -28
Cash Fr. Inv.
Cash Fr. Finan. 29
Net Change 0 0 0 2
Cash & Cash Eqvt 0 0 2

Shareholding Pattern View Details >>

2 Qtrs 2022-03 (%) 2022-09 (%)
Promoter 73.53 73.53
Public 26.47 26.47
Depository Receipts 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00

Announcements View Details >>

Fri, 27 Jan 2023
Statement On Deviation Or Variation Of Funds Under Regulation 32 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015
Pursuant to Regulation 32 of the SEBI Listing Regulations and SEBI Circular No. CIR/CFD/CMD1/162/2019 dated December 24 2019 please note that there are no deviation(s) or variation(s) in respect of the utilization of the proceeds of the Initial Public Offer (IPO) of the Company during the Half Year ended 30th September 2022 as mentioned in the object clause of the Prospectus dated 8th March 2022 Please find enclosed herewith a statement in this regard.A statement confirming that there is no deviation or variation in the utilisation of these proceeds is enclosed herewith.
Mon, 09 Jan 2023
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
With reference to the captioned subject we hereby submit the confirmation Certificate received from M/s. Accurate Securities & Registry Private Limited Registrar and Share Transfer Agent (RTA) as per Regulation 74(5) of the Securities and Exchange Board India (Depository and Participant) Regulations 2018 for the Quarter and Nine Months ended on 31st December 2022.
Tue, 08 Nov 2022
Submission Of Revised Unaudited Financial Results For The Half Year Ended On 30Th September 2022 Along With Limited Review Report
In reference to captioned subject and pursuant to Regulation 33(3) (d) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we are hereby submitting the Revised Unaudited Financial Results for the Half Year ended on 30th September 2022 along with Limited Review Report. Kindly take this revised result on your record and oblige us.Thanking You.Yours Faithfully

Technical Scans View Details >>

Wed, 01 Feb 2023
High Delivery Percentage High Delivery Percentage
Close Crossing Last Week Low Close Crossing Last Week Low
Close Crossing Last Month Close from Above Close Crossing Last Month Close from Above
Opening at High Opening at High
Opening at Low Opening at Low

Related Stocks View Details >>

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Adani Enterprises Ltd. 178,375.98 1,564.70 -26.5%
Redington Ltd. 14,349.07 183.60 +0.3%
MMTC Ltd. 4,980.00 33.20 -0.4%
Optiemus Infracom Ltd. 2,507.89 294.75 +7.5%
Landmark Cars Ltd. 2,434.32 612.00 -0.8%
SIRCA Paints India Ltd. 1,751.83 641.80 +2.5%
Polo Queen Industrial & Fintech Ltd. 1,698.89 50.95 +3.0%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Adani Enterprises Ltd. Consolidated 2022-09 145.84 1,564.70 -26.5%
Redington Ltd. Consolidated 2022-12 10.03 183.60 +0.3%
MMTC Ltd. Consolidated 2022-09 3.32 33.20 -0.4%
Optiemus Infracom Ltd. Consolidated 2022-09 242.68 294.75 +7.5%
Landmark Cars Ltd. Standalone 2022-03 69.57 612.00 -0.8%
SIRCA Paints India Ltd. Consolidated 2022-12 41.09 641.80 +2.5%
Polo Queen Industrial & Fintech Ltd. Consolidated 2022-09 758.27 50.95 +3.0%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Adani Enterprises Ltd. Consolidated 2022-09 5.65 1,564.70 -26.5%
Redington Ltd. Consolidated 2022-12 2.17 183.60 +0.3%
MMTC Ltd. Consolidated 2022-09 3.82 33.20 -0.4%
Optiemus Infracom Ltd. Consolidated 2022-09 7.20 294.75 +7.5%
Landmark Cars Ltd. Standalone 2022-03 2.94 612.00 -0.8%
SIRCA Paints India Ltd. Consolidated 2022-12 6.87 641.80 +2.5%
Polo Queen Industrial & Fintech Ltd. Consolidated 2022-09 10.52 50.95 +3.0%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Adani Enterprises Ltd. Consolidated 2022-03 1.82 1,564.70 -26.5%
Redington Ltd. Consolidated 2022-03 0.11 183.60 +0.3%
MMTC Ltd. Consolidated 2022-03 -17.70 33.20 -0.4%
Optiemus Infracom Ltd. Consolidated 2022-03 0.13 294.75 +7.5%
Landmark Cars Ltd. Standalone 2022-03 1.02 612.00 -0.8%
SIRCA Paints India Ltd. Consolidated 2022-03 0.00 641.80 +2.5%
Polo Queen Industrial & Fintech Ltd. Consolidated 2022-03 0.10 50.95 +3.0%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Adani Enterprises Ltd. Consolidated 2022-03 2.41 1,564.70 -26.5%
Redington Ltd. Consolidated 2022-03 24.61 183.60 +0.3%
MMTC Ltd. Consolidated 2022-03 0.00 33.20 -0.4%
Optiemus Infracom Ltd. Consolidated 2022-03 -0.28 294.75 +7.5%
Landmark Cars Ltd. Standalone 2022-03 31.70 612.00 -0.8%
SIRCA Paints India Ltd. Consolidated 2022-03 12.99 641.80 +2.5%
Polo Queen Industrial & Fintech Ltd. Consolidated 2022-03 0.89 50.95 +3.0%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Adani Enterprises Ltd. Consolidated 2022-03 2.41 1,564.70 -26.5%
Redington Ltd. Consolidated 2022-03 24.61 183.60 +0.3%
MMTC Ltd. Consolidated 2022-03 0.00 33.20 -0.4%
Optiemus Infracom Ltd. Consolidated 2022-03 -0.28 294.75 +7.5%
Landmark Cars Ltd. Standalone 2022-03 31.70 612.00 -0.8%
SIRCA Paints India Ltd. Consolidated 2022-03 12.99 641.80 +2.5%
Polo Queen Industrial & Fintech Ltd. Consolidated 2022-03 0.89 50.95 +3.0%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Adani Enterprises Ltd. Consolidated 2022-03 69,420.18 1,564.70 -26.5%
Redington Ltd. Consolidated 2022-03 62,644.01 183.60 +0.3%
MMTC Ltd. Consolidated 2022-03 11,796.24 33.20 -0.4%
Optiemus Infracom Ltd. Consolidated 2022-03 471.63 294.75 +7.5%
Landmark Cars Ltd. Standalone 2022-03 2,976.52 612.00 -0.8%
SIRCA Paints India Ltd. Consolidated 2022-03 200.02 641.80 +2.5%
Polo Queen Industrial & Fintech Ltd. Consolidated 2022-03 56.55 50.95 +3.0%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Adani Enterprises Ltd. Consolidated 2022-03 475.37 1,564.70 -26.5%
Redington Ltd. Consolidated 2022-03 1,314.87 183.60 +0.3%
MMTC Ltd. Consolidated 2022-03 -262.38 33.20 -0.4%
Optiemus Infracom Ltd. Consolidated 2022-03 -0.92 294.75 +7.5%
Landmark Cars Ltd. Standalone 2022-03 66.18 612.00 -0.8%
SIRCA Paints India Ltd. Consolidated 2022-03 27.72 641.80 +2.5%
Polo Queen Industrial & Fintech Ltd. Consolidated 2022-03 1.43 50.95 +3.0%

FAQ's On EVOQ Remedies Ltd.

What is EVOQ Remedies share price?

Can I buy EVOQ Remedies shares now?

What is the Market Cap of EVOQ Remedies?

What are the key metrics to analyse EVOQ Remedies?

What is the 52 Week High and Low of EVOQ Remedies?